Old variables, new value: A refined IPI for DLBCL

Jennifer A. Kanakry, Richard F. Ambinder

Research output: Contribution to journalReview article


In this issue of Blood, Zhou and colleagues present a refined prognostic index for patients with de novo diffuse large B-cell lymphoma (DLBCL), addressing the need for a tool that can better separate risk groups in the rituximab era.

Original languageEnglish (US)
Pages (from-to)800-801
Number of pages2
Issue number6
StatePublished - Feb 6 2014

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Old variables, new value: A refined IPI for DLBCL'. Together they form a unique fingerprint.

  • Cite this